-
Orthopedic Device Markets in China: The Growing Threat from Domestic Competition
This live session took place on Tuesday, July 24, 2018. Rapid growth in the Chinese orthopedic market and large foreseeable opportunities have attracted significant investment from both multinational...
-
The Next Big Thing in Migraine Prophylaxis: Anti-CGRP MAbs Poised to Take Center Stage
The migraine prophylaxis market is poised for disruption as four anti-CGRP monoclonal antibodies (MAbs) race to market. Amgen/Novartis’s Aimovig (erenumab) is in the pole position, and has become...
-
Oncology Pulse - Opdivo + Yervoy’s FDA Win for Colorectal Cancer – What Pharma Needs to Know
Opdivo + Yervoy's FDA Win for Colorectal Cancer – What Pharma Needs to Know Dr. Andrew Merron, Executive Director, DRG Oncology In July 2018, Opdivo + Yervoy received FDA approval for...
-
Market Snapshot: The US Market for Sports Medicine Devices
Do you know what innovations are driving the suture anchor market? Do you have a solid ASC strategy? Did you know that reprocessing affiliates are losing ground? Check out our snapshot of the...
-
Market Snapshot: Top Minimally Invasive Surgery Markets
Which players are leading the way in the trocars market? How are laparoscopic direct energy devices expected to evolve in the US? What does the future hold for endolinear staplers and cutters?...
-
PARP Inhibitor Cheat Sheet for Oncology Strategists
PARP inhibitors are hotly anticipated to become a key drug class in the treatment of select patients across several tumor types. What are some of the key takeaways pharma strategists should keep in...
-
IDN Rundown for Pharma Strategists
Integrated delivery networks (IDNs) are poised to transform the U.S. healthcare market.
-
Oncology Pulse - Oncology: The Big Picture and Key Dynamics Shaping the Market
Oncology: The Big Picture and Key Dynamics Shaping the Market Dr. Andrew Merron, Executive Director, DRG Oncology For the introductory episode of the DRG Oncology Pulse video series, Dr. Andrew Merron...
-
Treatment Sequencing: Navigating the Complex System of Pathways in the Oncology Ecosystem
Presenter: Rachel Webster, Principal Director, DRG Oncology Webinar Length: 9 minutes In today’s landscape, it’s challenging to get an accurate picture of the complex oncology clinical...
-
Key IDN Insights for Pharma Planning
The rise of IDNs is transforming the healthcare landscape, and changing the game for how pharma approaches its market access planning and customer engagement. This cheat sheet outlines the key areas...
A global consultancy and training agency providing market leading product & portfolio strategy, health economic outcomes research & evidence generation, value communication and training services across the life science industry.
We partner with both the biopharmaceutical and medical technology industry to support commercialization & patient access across a variety of functions including: R&D, commercial strategy, HEOR, market access, new product planning, marketing, data insights & analytics, business development and channel & segment customer engagement.
